HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful response to rituximab in a patient with pure red cell aplasia complicating chronic lymphocytic leukaemia.

AuthorsMontserrat Batlle, Josep-Maria Ribera, Albert Oriol, Esther Plensa, Fuensanta Millá, Evarist Feliu
JournalBritish journal of haematology (Br J Haematol) Vol. 118 Issue 4 Pg. 1192-3 (Sep 2002) ISSN: 0007-1048 [Print] England
PMID12199808 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents (therapeutic use)
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell (complications)
  • Male
  • Middle Aged
  • Red-Cell Aplasia, Pure (complications, drug therapy)
  • Rituximab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: